Immediate Treatment for COPD Exacerbation with Wheezing
Start immediately with nebulized short-acting β2-agonist (salbutamol 2.5-5 mg) combined with ipratropium bromide (0.25-0.5 mg), and administer systemic corticosteroids (prednisone 30-40 mg orally daily for 5-7 days). 1, 2
Initial Bronchodilator Therapy
The cornerstone of acute treatment is dual bronchodilation with both β2-agonists and anticholinergics. 1
- Administer nebulized salbutamol (albuterol) 2.5-5 mg combined with ipratropium bromide 0.25-0.5 mg immediately 2
- Continue at 4-6 hourly intervals, with more frequent dosing if needed based on clinical response 2
- During acute exacerbations, breathless patients may find nebulizers easier to use than metered-dose inhalers, though spacers and dry-powder devices can achieve good responses 1
- Short-acting β2-agonists produce bronchodilation within minutes, peaking at 15-30 minutes and lasting 4-5 hours 1
- Anticholinergic agents have slower onset (30-90 minutes) but provide 4-6 hours of effect with ipratropium 1
Systemic Corticosteroids
Corticosteroids are essential and should be started immediately alongside bronchodilators. 1, 2
- Administer prednisone 30-40 mg orally daily for 5-7 days 2, 3
- Oral corticosteroids are preferred over intravenous in hospitalized patients 3
- A 5-7 day course is sufficient; longer durations increase adverse effects without improving outcomes 3
- Systemic corticosteroids improve lung function (FEV1), oxygenation, and shorten recovery time and hospitalization duration 1
Antibiotic Therapy
Consider antibiotics if there is evidence of bacterial infection, particularly with purulent sputum. 1
- Initiate antibiotics if the patient has altered sputum characteristics (purulence and/or increased volume) 3
- Common pathogens include Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis 1, 3
- First-line options include amoxicillin, tetracycline derivatives, amoxicillin/clavulanic acid, cephalosporins, doxycycline, or macrolides 1, 3
- Treat empirically for 7-14 days when sputum becomes purulent 1
- Antibiotics shorten recovery time and reduce risk of early relapse, treatment failure, and hospitalization duration 1
Critical Assessment and Monitoring
Even with wheezing as the presenting symptom, assess for respiratory failure and need for ventilatory support. 2
- Obtain arterial blood gases immediately, even if pulse oximetry appears normal, as oxygen saturation can be misleadingly normal while CO2 retention and respiratory acidosis develop 2
- A pH below 7.26 predicts poor outcomes and may require non-invasive ventilation (NIV) 2
- NIV should be the first mode of ventilation if respiratory acidosis (pH <7.26) is present 1, 2, 3
- Differentiate from other conditions: acute coronary syndrome, worsening heart failure, pulmonary embolism, and pneumonia 1
Oxygen Therapy
Provide controlled oxygen therapy if hypoxemia is present, targeting PaO2 ≥60 mmHg or SpO2 ≥90%. 2, 3
- Controlled oxygen may be needed even if initial SpO2 appears adequate 2
- Prevention of tissue hypoxia takes precedence over CO2 retention concerns 3
- Goal is PaO2 ≥60 mmHg (6.6 kPa) without causing pH to fall below 7.26 2
Medications to Avoid
Do not use methylxanthines (theophylline, aminophylline) as they are not recommended due to side effects. 1, 4
- Methylxanthines should only be considered if the patient is not responding to first-line treatments 3
- They provide little additional benefit in patients receiving frequent inhaled bronchodilators and adequate corticosteroids 5
Common Pitfalls
- Do not delay systemic corticosteroids while waiting for response to bronchodilators alone 1
- Avoid relying solely on pulse oximetry without arterial blood gas analysis in moderate-to-severe presentations 2
- Do not use chest physiotherapy in acute exacerbations 3
- Avoid intravenous β2-agonists as they offer no advantage over inhaled routes in most acute exacerbations 1
Post-Acute Management
Before discharge, initiate maintenance therapy with long-acting bronchodilators. 1, 2, 4